CORE RESOURCES:

• Rutherford's Vascular and Endovascular Therapy 10th Edition, Chapters 88, 89, 91, and 94

• Atlas of Vascular Surgery and Endovascular Therapy 2nd Edition, Chapter 9

ADDITIONAL RESOURCES:

Audible Bleeding Episodes

• Holding Pressure - Carotid Endarterectomy: https://www.audiblebleeding.com/2024/02/27/holding-pressure-carotid-endarterectomy/

• Holding Pressure Case Prep - Endovascular Basics: https://www.audiblebleeding.com/2023/04/23/holding-pressure-case-prep-endovascular-basics/

Videos

• TCAR Technical Video: https://jnis.bmj.com/content/14/8/842

Articles

• Society for Vascular Surgery clinical practice guidelines for management of extracranial cerebrovascular disease: https://www.jvascsurg.org/article/S0741-5214%2821%2900893-4/fulltext

• Technical aspects of transcarotid artery revascularization using the ENROUTE transcarotid neuroprotection and stent system: https://www.jvascsurg.org/action/showPdf?pii=S0741-5214%2816%2931862-6

Referenced Studies

• ROADSTER-1

• https://pubmed.ncbi.nlm.nih.gov/30611582/

• ROADSTER-2

• https://pubmed.ncbi.nlm.nih.gov/32811386/

• https://pubmed.ncbi.nlm.nih.gov/35381327/

• TCAR Surveillance Project

• https://jamanetwork.com/journals/jama/fullarticle/2757579?utm_source=openevidence&utm_medium=referral

• https://pubmed.ncbi.nlm.nih.gov/36172943/

OUTLINE:

CAROTID ARTERY DISEASE

1. Pathophysiology/etiology

1. Carotid artery disease is primarily driven by atherosclerotic plaque deposition.

2. Risk factors: hypertension, hyperlipidemia, diabetes, smoking, and advanced age.

3. Nonatherosclerotic etiologies: fibromuscular dysplasia, carotid dissection, vasculitic disease, carotid webs, and trauma.

4. When the endothelium is damaged, monocytes migrate to the site and differentiate into macrophages that take up oxidized LDL particles to become foam cells. Meanwhile, an inflammatory response occurs where activated platelets release thromboxane A2, platelet derived growth factor, and inflammatory cytokines that promote further platelet aggregation and vascular inflammation. Smooth muscle cells migrate and proliferate, forming the structural framework of the atheroma.

5. Within the lesion, necrotic debris and lipid accumulate, creating a vulnerable plaque. Plaque rupture exposes this material to the bloodstream, serving as a nidus for thrombus formation which can lead to ischemic events.

6. Carotid bifurcation is particularly prone to plaque formation due to turbulent blood flow. Embolization of plaque from this area can result in TIA or ischemic stroke.

2. Presentation

1. Patients are often asymptomatic and stenosis is incidentally found on imaging.

2. Symptomatic patients present with neurologic symptoms including unilateral motor and sensory loss, aphasia (difficulty finding words), dysarthria (difficulty speaking), amaurosis fugax (temporary monocular vision loss due to embolus to the ophthalmic artery), transient ischemic attacks

3. Physical exam findings may be notable for auscultation of a carotid bruit. Patients may also have evidence of retinal artery embolization on fundoscopic examination (Hollenhorst plaque) or asymptomatic cerebral infarction.

3. Diagnosis

1. USPTF recommends against screening for asymptomatic carotid artery stenosis.

2. In patients with no risk factors, SVS recommends against screening for asymptomatic carotid artery stenosis. However, they do recommend screening for asymptomatic clinically significant carotid bifurcation in certain groups of patients with multiple risk factors.

3. These risk factors include patients with clinically significant peripheral vascular disease, patients 65 and older with history of CAD, smoking, hypercholesterolemia, and patients prior to coronary artery bypass.

4. Relevant findings on physical exam or imaging findings may warrant screening, but screening is not recommended for the presence of neck bruit alone without other risk factors, as this finding has a low sensitivity and specificity for detecting clinically significant carotid artery stenosis.

5. Carotid duplex ultrasound: first-line imaging modality for both screening and initial evaluation of stenosis, noninvasive, low-cost

6. CTA: rapid, high-resolution, three-dimensional imaging of vascular anatomy, risk of contrast and radiation exposure

7. MRA: high-quality, three-dimensional imaging without radiation or contrast, expensive with longer acquisition time, can overestimate stenosis in severe disease

8. DSA/angiography: gold standard, expensive, invasive, not generally recommended for routine diagnostic evaluation or screening

4. Classification

1. Carotid artery stenosis is classified by degree of luminal narrowing.

2. NASCET method: standard in current practice. Compares the minimal residual lumen at the point of greatest stenosis to the diameter of the normal distal internal carotid artery.

3. Classification of stenosis:

   1. Mild:

   2. Moderate: 50-69% narrowing

   3. Severe: ≥70% narrowing

TRANSCAROTID ARTERY REVASCULARIZATION (TCAR)

5. Relevant Trials

1. ROADSTER-1 trial: prospective, multicenter, single-arm study evaluating TCAR with dynamic flow reversal in patients at high risk for carotid endarterectomy (CEA), including both symptomatic (≥50% stenosis) and asymptomatic (≥80% stenosis) patients.

   1. 30-day stroke rate of 1.4% and a combined stroke/death/MI rate of 3.5%, with technical success in 99% of cases

   2. At 1 year, the ipsilateral stroke rate was 0.6%, indicating excellent durability in a high-risk population

   3. Limitations: highly controlled environment with a select group of experienced operators, which raised concerns about the generalizability, especially among physicians new to TCAR. Additionally, ROADSTER-1 was a single-arm study without a comparison group.

2. ROADSTER-2: prospective, multicenter, post-approval registry format. Addressed limitations of ROADSTER-1 by enrolling a larger and more diverse group of operators, the majority of whom were TCAR-naïve.

   1. The per-protocol population had a 30-day stroke rate of 0.6% and a combined stroke/death rate of 0.6%, with technical success in 99.7% of cases. These results confirmed the low perioperative stroke and death rates seen in ROADSTER-1, even with less experienced operators.

3. TCAR Surveillance Project: ongoing study that provides real-world, comparative data using the VQI registry.

   1. In propensity-matched analyses, TCAR had similar in-hospital stroke/death rates to CEA (1.6% vs 1.6%) and significantly lower rates than transfemoral carotid artery stenting (TF-CAS, 2.9%).

   2. TCAR was also associated with significantly lower cranial nerve injury and myocardial infarction rates compared to CEA (0.7 vs 2.4%, and 0.5 vs 0.9%, respectively).

   3. At 1 year, stroke/death rates remained similar between TCAR and CEA (5.1-6.4% vs 5.2-6.6%, respectively), but TCAR outperformed TF-CAS (5.1-6.4% vs 9.6-9.7%).

6. Indications for Surgery

1. All patients with carotid artery stenosis benefit from best medical therapy (BMT): antiplatelet, high-intensity statin, aggressive risk factor control, and lifestyle modification.

2. Asymptomatic patients: ≥70% stenosis, provided the anticipated perioperative risk for stroke, MI, or death is <3%. The decision to intervene in asymptomatic patients is more nuanced due to advances in medical therapy and lower contemporary stroke rates. Life expectancy should also be taken into consideration.

3. Symptomatic patients: >50% stenosis, benefit of revascularization increases with higher degrees of stenosis.

   1. Carotid intervention for symptomatic patients should be performed 2-14 days after stroke.

4. TCAR anatomic criteria:

   1. Internal carotid artery diameter 4-9mm

   2. Clavicle-carotid bifurcation distance ≥ 5cm

   3. Common carotid artery (CCA) diameter ≥ 6mm

   4. No or mild puncture site plaque

5. TCAR may be more favorable than CEA in patients who have a high lesion at or above C2 vertebral level, high carotid bifurcation, "hostile neck" (restenosis post-CEA, cervical spine immobility, history of neck irradiation or radical neck dissection)

6. Contraindications: 100% occlusion, or patients with severe comorbidities or life expectancy 3, unsuitable anatomy or an inability to tolerate flow reversal

7. Surgery

1. Preop

   1. DAPT at least 3 days and statin for 5 days to reduce periprocedural risk of stroke and mortality.

   2. Anesthesia: general anesthesia or MAC

   3. Positioning: supine position with the head extended and turned to the contralateral side. The neck and contralateral groin are prepped and draped in sterile fashion.

2. Steps to the procedure and relevant anatomy

Common carotid artery exposure

1. Identify the triangle created by the sternal and clavicular heads of the sternocleidomastoid muscle (SCM) and the superior edge of the clavicle.

2. Create a 2- to 4-cm longitudinal or transverse incision between the two heads.

3. Electrocautery is used to divide through the subcutaneous tissue and platysma.

4. The SCM is retracted laterally to access the carotid sheath.

5. The carotid sheath contains three critical structures. From medial to lateral we have the common carotid artery, vagus nerve, and internal jugular vein.

6. The internal jugular vein is dissected and retracted.

7. A branch off of the internal jugular vein that we commonly encounter is the facial vein. This can be safely ligated when encountered.

8. In most patients, the vagus nerve lies lateral and posterior to the common carotid artery and care should be taken to avoid injury to it, especially in the later steps when we get to clamping the artery.

9. Other critical structures:

   1. Hypoglossal nerve: crosses the carotid artery transversely approximately 2-3 cm above the carotid bifurcation

   2. Ansa cervicalis: encountered in the carotid sheath as it branches from the hypoglossal nerve as it crosses the internal carotid artery

   3. Carotid body: at the base of the carotid bifurcation

   4. Marginal mandibular branch of the facial nerve: encountered at higher incisions, though this is not as common as with carotid endarterectomies

10. Once the common carotid artery is dissected and exposed, a vessel loop or umbilical tape is placed to facilitate manipulation of the vessel during carotid artery access.

11. A purse string or U-stitch 5-0 polyproline suture is placed on the common carotid for the closure of the arterial puncture site at the end of the procedure.

Femoral vein access

1. Femoral triangle anatomy:

   1. Borders

      1. Superior: inguinal ligament

      2. Lateral: medial border of the sartorius muscle

      3. Medial: lateral border of the adductor longus muscle

   2. Contents

      1. Lateral to medial: femoral nerve, femoral artery, femoral vein, empty space/femoral canal, and lymphatics

      2. Mnemonic - NAVEL: nerve, artery, vein, empty space, lymphatics

2. Using ultrasound guidance, the femoral vein contralateral to the common carotid artery we just exposed is visualized.

3. The common femoral vein is typically accessed 1-2 cm below the inguinal ligament and is around 2-4 cm deep to the skin in most adults. We access the vein with a micropuncture system via Seldinger technique.

4. The TCAR venous return sheath is advanced over a 0.035-inch guidewire. Blood is aspirated from the flow line and the sheath is flushed with heparinized saline to ensure proper access.

5. Secure the venous return sheath with suture.

6. The contralateral femoral vein is accessed to facilitate optimal circuit setup and minimize interference with arterial access and other steps.

Common carotid artery access and sheath placement

1. Heparin should be given prior to obtaining arterial access. An activated clotting time, also known as ACT, between 250-300 should be achieved.

2. Obtain micropuncture access of the common carotid at the site where we previously placed the suture. A 21-gauge micropuncture needle is slowly advanced into the anterior wall of the common carotid artery and a 0.018-inch micropuncture wire is advanced 3 cm into the common carotid artery. A micropuncture sheath and dilator are advanced 2-3 cm into the common carotid.

3. After removal of the dilator and micropuncture wire, brisk and pulsatile backbleeding confirms correct positioning.

4. Angiogram is obtained to delineate the carotid bifurcation and where the lesion is located.

5. A 0.035-inch ENROUTE J wire is positioned in the CCA, the micropuncture sheath is removed, and the arterial sheath and dilator are inserted (stop short technique).

6. The arterial access sheath is advanced to the 2.5-cm marker, predetermined by the sheath stopper.

7. The sheath position should be checked using angiography in two projections after removal of the dilator to ensure the sheath tip is placed coaxially within the common carotid.

8. Secure the sheath to the patient at 3 points using 2-0 silk stitches. The side ports are burped and a control run confirms no evidence of dissection or vessel injury.

Initiation of dynamic flow reversal

1. The flow controller is connected to the arterial access sheath. The column should be held upward and arterial blood should fill the column.

2. Once it fills to the line on the controller, connect the system to the venous return sheath. You have now established an extracorporeal AV shunt.

3. The integrity of the circuit is verified by flushing the venous sheath with hep saline and confirming rapid blood flow through the circuit.

4. Perform a TCAR time out, confirming systolic blood pressure 140–160 mmHg, heart rate >70 bpm, and ACT >250 seconds to optimize cerebral perfusion and minimize thrombotic risk.

5. Clamp the carotid artery just proximal to the arterial sheath to establish active flow reversal.

6. Flow controller settings:

   1. Low setting

   2. High setting

   3. Flow-stop button: allows for temporary cessation of flow (used when we inject contrast).

7. Confirm flow reversal via two different ways:

1. The first way is to stop flow to the venous return sheath with the stopcock, clearing the line with hep saline injection, and then opening the stopcock and seeing the blood returning to the controller in a reverse fashion.

2. The second way is to perform an angiogram with a small amount of contrast injection while holding the flow-stop button. Using the angio we want to make sure that contrast is flowing retrograde in the cervical ICA thereby confirming flow reversal.

Carotid artery stenting, balloon angioplasty, and completion angiogram

1. At this point, a standard carotid angioplasty and stenting procedure is performed.

2. ENROUTE transcarotid Neuroprotection System device:

   1. inner diameter of 8F and an outer diameter of 10F

   2. Has its own carotid artery stent system but is also compatible with all FDA-approved carotid stents.

3. Final angiogram is performed to confirm stent position, vessel patency, and absence of complications including vasospasm at the distal end of the stent and filling defects from protrusion of atheromatous material through the stent

Cessation of flow reversal and sheath removal

1. Allow the flow reversal to run for a few minutes after the final balloon angioplasty to clear any debris.

2. Antegrade flow is restored by releasing the carotid clamp and closing the stopcocks on the neuroprotection system.

3. The patient is auto-transfused the blood from the flow line back to the venous system.

4. As the arterial access system is removed and the puncture site is closed with the U-stitch.

5. IV protamine is administered to reverse the heparin.

6. Standard closure is performed at the incision site. Meanwhile, hemostasis is achieved after removal of the femoral vein sheath with brief manual compression.

1. Postop care/complications

   1. Postop care

      1. All patients after a TCAR should be monitored in the ICU setting for 24 hours, as an embolic stroke, hypotension with or without bradycardia, or hypertension can occur.

         1. Should a TIA or stroke be observed, a carotid duplex scan and CT angiogram should be immediately obtained to assess the stent site and the presence of an embolic or thrombotic filling defect, dissection, or occlusion.

      2. Dual antiplatelet therapy: continue for 45 days to 12 months

      3. Aspirin and statin therapy: continued indefinitely

      4. Surveillance duplex imaging: 4 weeks, 6 months, and 12 months, and annually thereafter.

   2. Postop complications

      1. Hematoma

      2. Stroke

      3. Myocardial infarction

      4. Cerebral hyperperfusion syndrome

         1. Sudden and excessive increase in cerebral blood flow to previously hypoperfused brain tissue is met with vasculature that cannot constrict appropriately from chronic vasodilation

         2. Leads to breakthrough hyperperfusion. This results in cerebral edema, intracerebral hemorrhage, and neurological symptoms.

      5. Cranial nerve injury

         1. Hypoglossal nerve (CN XII) injury: ipsilateral tongue deviation. It is the most commonly injured cranial nerve.

         2. Vagus nerve (CN X) injury: hoarseness and possible vocal cord paralysis.

         3. Glossopharyngeal nerve (CN IX) injury: soft palate dysfunction.

         4. Recurrent laryngeal nerve injury: voice hoarseness and inability to cough as it innervates all of the voice box muscles except for the cricothyroid muscle

         5. Marginal mandibular nerve injury: ipsilateral lip droop, injury is rare in TCAR.

      6. Stent restenosis

      7. Pseudoaneurysm

      8. Access site infection

Welcome back to the Audible Bleeding series: Landmark Papers in Vascular Surgery. In this episode, co-hosts John and Dr. Jesse Columbo are joined by our guest, Dr. Caitlin Hicks, to discuss one of the most studied—and most debated—topics in vascular surgery: asymptomatic carotid stenosis.

In this episode, we'll trace that evolution through three pivotal trials: ACAS and ACST-1, which established carotid endarterectomy as the standard of care; and the newly published CREST-2, which challenges us to reconsider everything we thought we knew. Along the way, we'll explore how advances in statin therapy, blood pressure control, and antiplatelet agents have fundamentally changed the natural history of this disease—and what that means for our patients today."

Links to Landmark Papers:

1. (ACAS) Endarterectomy for Asymptomatic Carotid Artery Stenosis

1. (ACST-1) 10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis: a multicentre randomised trial

1. (CREST-2) Medical Management and Revascularization for Asymptomatic Carotid Stenosis

Guests:

Dr. Caitlin Hicks, MD (@CaitlinWHicks); Associate Fellowship Program Director, Vascular Surgery & Endovascular Therapy at Johns Hopkins and Director of Research

Hosts:

John Culhane, MD (@JohnCulhaneMD); General Surgery Resident, Abrazo Health

Dr. Jesse Columbo, MD; Assistant Professor of The Dartmouth Institute, Geisel School of Medicine, Dartmouth

Follow us @audiblebleeding,

Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

*Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.

Audible Bleeding editors Falen Demsas, an integrated vascular surgery resident at Massachusetts General Hospital, and Sasank Kalipatnapu (@ksasank), a fifth-year general surgery resident at UMass Chan Medical School, are joined by Megan Tracci (@MeganTracci), James Black (@JamesHBlackMD), and Lauren West-Livingston (LWestLivingston) for a discussion following the inaugural SVS Leadership and Advocacy Summit.

In this episode, the group reflects on the importance of surgeon advocacy, highlights key takeaways from the Summit, and discusses how vascular surgeons throughout training and practice can engage in policy, leadership, and organized medicine at local and national levels. The conversation explores the evolving role of advocacy within the Society for Vascular Surgery, including the work of the SVS Advocacy Council and its collaboration across Government Relations, Coding, VA advocacy, and quality and policy initiatives.

Dr. Tracci shares insights from her leadership roles within SVS advocacy efforts and her work as ACS Medical Director for Surgeon Engagement. Dr. Black discusses his longstanding advocacy work on behalf of patients and physicians, including numerous trips to Capitol Hill over the course of his career. Dr. West-Livingston reflects on her experience attending the recent Advocacy & Leadership Conference as a trainee and the importance of resident involvement in advocacy work.

• Megan Tracci Leader within the SVS Advocacy Council, which includes Government Relations, Coding, VA advocacy, and quality and policy collaboration efforts. She also serves as the ACS Medical Director for Surgeon Engagement.
• James Black Chief of Vascular Surgery and Endovascular Therapy at Johns Hopkins University and longtime advocate who has made countless trips to Capitol Hill to advocate for patients and physicians.
• Lauren West-Livingston Integrated vascular surgery resident at Duke University and member of the SVS Government Relations Committee who attended the recent Advocacy & Leadership Conference.

• The inaugural SVS Leadership and Advocacy Summit
• Advocacy efforts within the Society for Vascular Surgery, including Government Relations, Coding, VA advocacy, and quality and policy collaboration. Learn more here SVS Advocacy Council
• Opportunities for vascular surgeons to engage in advocacy throughout all stages of training and practice. Sign up for updates

Follow us @audiblebleeding

Learn more about us at Audible Bleeding and provide us with your feedback through our listener survey.

Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.

Audible Bleeding editor Wen (@WenKawaji) discusses international vascular surgery fellowships with Dr. Judith Lin (@JudithLin4), Dr. Adam Johnson, and Dr. Robbie Aru (@AruRobbie). Together, they reflect on what drove them abroad, what the experience actually looked like on the ground, and the professional, financial, and personal challenges that came with it. Whether you're a resident exploring your options or simply curious about roads less traveled in surgical training, this conversation offers a candid and practical look at what international fellowships in vascular surgery really entail. A must-listen for anyone considering fellowship training outside the U.S.

Articles:

• A contemporary guide to an international aortic super-fellowship for surgical trainees and surgeons in the United States

Show Guests

• Dr. Judith Lin: professor and chief of vascular surgery in the Department of Surgery at Michigan State University's College of Human Medicine

• Dr. Adam Johnson: assistant professor of surgery and assistant professor in population health science at Duke university school of medicine

• Dr. Robbie Aru: assistant professor of surgery at Thomas Jefferson university medical college

Follow us @audiblebleeding

Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

*Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.

In this episode, we spotlight editorials and abstracts from the Journal of Vascular Surgery Cases, Innovations, and Techniques (JVS-CIT). Editorials and Abstracts are read by Authors as well as members of the SVS Social Media Ambassadors.

Guests:

Isabel Banks, MS4, SLU

1. Selected publications regarding lower extremity chronic ischemia and the diabetic foot from the Journal of Vascular Surgery: Cases and Innovative Reports 2025, Volume 11

1. Best of 2025—abdominal aortic and iliac aneurysm

1. Double anonymous peer review in JVSCIT—lessons from our pilot trial and next steps

1. Endovascular stapling with Aortoseal as an adjunct for the hostile neck

1. The transcaval approach may be the new route vascular surgeons need in their arsenal

1. Intraoperative positioning system-guided antegrade in situ laser fenestration in an aortic model

1. Single-center experience using Endologix anatomically fixated endograft device for treatment of aortoiliac occlusive disease

1. Short-term analysis of botulinum toxin A for functional popliteal artery entrapment syndrome

1. Comparing neurological complications between endovascular and open surgical repair of the descending thoracic aorta

Hosts:

John Culhane (@JohnCulhaneMD)

Follow us @audiblebleeding, @JVS-CIT

Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

*Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.

Audible Bleeding editor Wen Kawaji (@WenKawaji) is joined by integrated vascular surgery resident Falen Demsas, 5th-year general surgery resident Sasank Kalipatnapu (@ksasank), JVS editor Dr. Duncan (@ADuncanVasc), and JVS-VL editor Dr. Ruth Bush to discuss some of our favorite articles in the JVS family of journals. This episode hosts Dr. Weaver, student doctor Finn, Dr. Sridharan, and Dr. Anan.

Articles:

• Evaluating the Vascular Quality Initiative's role in advancing minority health and health disparities research―a scoping review

• Catheter-directed interventions versus surgical embolectomy in massive pulmonary embolism

Show Guests

• Dr. Weaver: assistant professor of surgery and associate program director of the vascular surgery fellowship at the University of Utah. She is also the director of clinical operations efficiency at the University of Utah.

• Finn Repella: rising 4th medical student at the University of Virginia

• Dr. Sridharan: associate professor at the University of Pittsburgh Medical Center (UPMC). Site Chief of vascular surgery at UPMC Mercy.

• Dr. Anan: research fellow in the division of vascular surgery at the University of Pittsburgh Medical Center (UPMC). She earned her MD from the American University of Beirut.

Notable mentions:

• From Bench to Bill: How a Transplant Nuance Became 1 of Only 57 Laws Passed in 2013

Follow us @audiblebleeding

Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

*Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.

Audible Bleeding Editor and vascular surgery fellow Richa Kalsi (@KalsiMD) is joined by 5th year general surgery resident Amol Kamat, JVS editor Dr. Audra Duncan (@ADuncanVasc), and JVS-VS editor Dr. John Curci (@CurciAAA) to discuss two great articles in the JVS family of journals. This episode hosts medical student Neha Shetty (LinkedIn), Dr. Katherine Reitz (@MollReitz), Dr. Yasir Alsiraj, and Dr. Linda Cassis.

Articles:

• Part 1: Prioritizing high-volume repair hospitals with ruptured abdominal aortic aneurysms, for rural and nonrural patients (Shetty & Reitz)
• Part 2: Role of adipocyte angiotensinogen or angiotensin type 1a receptors in the development of diet-induced atherosclerosis or angiotensin II-induced abdominal aortic aneurysms (Alsiraj & Cassis)

Show Guests

• Neha Shetty is currently a medical student within the University of Pittsburgh School of Medicine's Class of 2027
• Dr. Katherine Reitz is an Associate Professor of Surgery at the University of Pittsburgh School of Medicine.
• Dr. Yasir Alsiraj is an Assistant Professor of Pharmacology and Nutritional Sciences, Pediatrics, at the Saha Aortic Center at the University of Kentucky.
• Dr. Cassis is the Vice President of Research at the University of Kentucky College of Medicine.

Follow us @audiblebleeding

Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

*Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.

Jacob Soucy (@JacobWSoucy) hosts an inside look at a timely and thought-provoking editorial published in The Vascular Specialist, the official news magazine of the Society for Vascular Surgery.

In this episode, we explore the evolving conversation around surgical call and compensation through the lens of the editorial "A Call for Call Pay." The discussion challenges the traditional framing of call as simply part of the job and instead examines it as a measurable burden of availability that carries legal, financial, and personal implications. This conversation highlights why the valuation of call may represent one of the defining structural issues in modern vascular surgery practice.

Jacob speaks with Dr. Malachi G. Sheahan III about the motivation behind the piece, how hospital systems value call, what the true cost of call coverage is, and what the future may hold if the current model remains unchanged.

Show Guest

Dr. Malachi G. Sheahan III is Professor and Chair of Surgery at Louisiana State University Health Sciences Center and Chief of the Division of Vascular Surgery. He previously served as Program Director for both the fellowship and integrated residency in vascular surgery at LSU. Nationally, Dr. Sheahan serves as Secretary of the Society for Vascular Surgery and as Chief Medical Editor of The Vascular Specialist. With more than two decades in academic surgery, he is a recognized leader in vascular education, workforce policy, and advocacy within the specialty.

Resources and Social Media

X (Twitter): @lsuvascular

Read the editorial: "A Call for Call Pay" – The Vascular Specialist

Special thanks to Dr. Malachi G. Sheahan III for sharing his time and insight and for his ongoing contributions to vascular surgery.

Follow us @audiblebleeding for updates on upcoming episodes and new research features. Learn more about us at audiblebleeding/about and share your feedback through our listener survey.

*Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.

Audible Bleeding editor Wen Kawaji (@WenKawaji) and 5th-year general surgery resident Sasank Kalipatnapu (@ksasank) from UMass Chan Medical School host SVS QPMC leadership Dr. Shutze, Dr. Hicks and Carrie McGraw to take a deep dive into the Vascular Surgery–specific Merit Based Incentive Payment System Value Pathway or MVP.

Show Guests

• Dr. William Shutze: Associate Professor at Texas A&M College of Medicine at Texas A&M Health Science Center in Dallas Texas. He is a managing partner at Texas Vascular Associates. He is the co-chair for the SVS Vascular Center Verification and Quality Improvement program, vice chair for the SVS QPMC committee

• Dr. Caitlin Hicks: Associate professor at Johns Hopkins University school of medicine, vice chair of research in the department of surgery. Chair for the SVS QPMC committee

• Carrie McGraw: SVS manager of Quality Improvement and Practice

Important resources

• 2026 Vascular MVP PDF: https://qpp-cm-prod-content.s3.amazonaws.com/uploads/3100/Vascular-Surgery-MVP-Candidate.pdf

• SVS Quality improvement contact email:

[email protected]

• Vascular Specialist article:

https://vascularspecialistonline.com/introducing-the-vascular-surgery-mips-value-pathway-a-new-era-for-meaningful-specialty-driven-quality-reporting/

Follow us @audiblebleeding

Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

*Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.

Audible Bleeding editor Wen Kawaji (@WenKawaji) is joined by Dr. Danielle Garcia, Dr. James Martinson, JVS editor Dr. Duncan (@ADuncanVasc), JVS-CIT editor Dr. Smeds (@MattSmeds) to discuss some of our favorite articles in the JVS family of journals. This episode hosts Dr. Ullery, Dr. Bath, Dr. Lee, and Dr. Satam.

Articles:

• Laser in situ fenestrated endograft (LIFE) repair of complex aortic arch pathology: Early outcomes from the multicenter LIFE registry

• A novel approach to thoracic endovascular aortic repair using "zone 1.5" deployment of the Gore thoracic branched endoprosthesis device

Show Guests

• Dr. Ullery has served as the medical director of vascular and endovascular surgery at the Providence heart and vascular institute since 2017 and is the co-founder of the Laser In-Situ Fenestration of Aortic Endografts (LIFE) Registry

• Dr. Bath is a practicing Vascular Surgeon at the University Hospital of the University of Missouri

• Dr. Lee is the chief of vascular surgery at Stanford Medicine

• Dr. Satam is a current vascular surgery resident in her PGY3 year at Stanford

Follow us @audiblebleeding

Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.

*Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.